J.M. Arbour’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Sell
253
-11
-4% -$11.2K 0.26% 96
2026
Q1
$243K Sell
264
-41
-13% -$41.6K 0.23% 108
2025
Q4
$328K Buy
+305
New +$292K 0.33% 80

Other funds holding LLY

J.M. Arbour's LLY Position: Q2 2026 in Review

J.M. Arbour reduced its Eli Lilly (LLY) stake by 4.2% in Q2 2026, selling an estimated $11.2K and leaving 253 shares worth $303K. The position accounts for 0.26% of the portfolio, ranked #96.

J.M. Arbour first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $328K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • J.M. Arbour held 253 shares of Eli Lilly worth $303K as of Q2 2026.
  • J.M. Arbour sold 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.26% of J.M. Arbour's portfolio in Q2 2026, its #96 holding.
  • J.M. Arbour first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • J.M. Arbour's Eli Lilly position peaked at $328K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on J.M. Arbour's 13F filing for Q2 2026, filed 14 Aug 2026.